SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '0RA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 9 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.77A | 1aj6A-4em7A:28.3 | 1aj6A-4em7A:51.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IWI_A_CAMA418_0 (CYTOCHROME P450-CAM) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 4 / 8 | LEU A 204VAL A 76ASP A 78VAL A 66 | NoneNone0RA A 301 (-3.6A)None | 0.96A | 1iwiA-4em7A:undetectable | 1iwiA-4em7A:19.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASP A 54GLU A 55ASP A 78ARG A 81ILE A 98ARG A 140THR A 172 | None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.65A | 1kijA-4em7A:28.6 | 1kijA-4em7A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASP A 54GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98THR A 172 | None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.73A | 1kijA-4em7A:28.6 | 1kijA-4em7A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.49A | 1kijB-4em7A:29.3 | 1kijB-4em7A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.71A | 1kijB-4em7A:29.3 | 1kijB-4em7A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 12 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.45A | 1s14A-4em7A:26.1 | 1s14A-4em7A:39.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 12 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.53A | 1s14A-4em7A:26.1 | 1s14A-4em7A:39.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 12 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83ILE A 98ARG A 140 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)None0RA A 301 (-2.5A) | 0.52A | 1s14B-4em7A:28.2 | 1s14B-4em7A:39.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 12 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None | 0.56A | 1s14B-4em7A:28.2 | 1s14B-4em7A:39.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 12 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.52A | 3lpsA-4em7A:29.0 | 3lpsA-4em7A:31.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81MET A 83ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.51A | 3lpsA-4em7A:29.0 | 3lpsA-4em7A:31.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CP4_A_CAMA416_0 (CYTOCHROME P450-CAM) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 4 / 7 | LEU A 204VAL A 76ASP A 78VAL A 66 | NoneNone0RA A 301 (-3.6A)None | 1.00A | 4cp4A-4em7A:undetectable | 4cp4A-4em7A:19.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E0F_A_RBFA301_1 (RIBOFLAVIN SYNTHASESUBUNIT ALPHA) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 5 / 11 | SER A 210VAL A 207GLU A 55ALA A 56HIS A 79 | NoneNone0RA A 301 (-3.4A)NoneNone | 1.09A | 4e0fA-4em7A:0.4 | 4e0fA-4em7A:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E0F_A_RBFA301_1 (RIBOFLAVIN SYNTHASESUBUNIT ALPHA) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 5 / 11 | SER A 210VAL A 207LEU A 209GLU A 55HIS A 79 | NoneNoneNone0RA A 301 (-3.4A)None | 0.97A | 4e0fA-4em7A:0.4 | 4e0fA-4em7A:24.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 11 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)0RA A 301 ( 3.9A) | 0.81A | 4urnA-4em7A:30.8 | 4urnA-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 11 | ASN A 51GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.92A | 4urnA-4em7A:30.8 | 4urnA-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 11 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.82A | 4urnB-4em7A:28.1 | 4urnB-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 11 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.76A | 4urnB-4em7A:28.1 | 4urnB-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 11 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.82A | 4urnC-4em7A:30.8 | 4urnC-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 9 / 11 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 ( 3.9A) | 0.73A | 4urnC-4em7A:30.8 | 4urnC-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98SER A 124ARG A 140 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)NoneNone0RA A 301 (-2.5A) | 0.66A | 4uroA-4em7A:29.5 | 4uroA-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98SER A 124 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)NoneNone | 0.71A | 4uroA-4em7A:29.5 | 4uroA-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98SER A 124ARG A 140 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)NoneNone0RA A 301 (-2.5A) | 0.74A | 4uroB-4em7A:29.5 | 4uroB-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98SER A 124 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)NoneNone | 0.73A | 4uroB-4em7A:29.5 | 4uroB-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 7 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98SER A 124ARG A 140 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)NoneNone0RA A 301 (-2.5A) | 0.74A | 4uroC-4em7A:29.5 | 4uroC-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 6 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)None | 0.73A | 4uroC-4em7A:29.5 | 4uroC-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98SER A 124ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)NoneNone0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.67A | 4uroD-4em7A:29.4 | 4uroD-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) | 8 / 12 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98SER A 124THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)NoneNone0RA A 301 ( 3.9A) | 0.73A | 4uroD-4em7A:29.4 | 4uroD-4em7A:53.85 |